The Tina’s Wish NextGen NYC and NextGen Boston committees are made up of young professionals committed to bringing the important work of Tina’s Wish to the next generation.
For more information or to get involved with the NextGen NYC or NextGen Boston Committee, please contact Kelly Cancelmo at kcancelmo@tinaswish.org.
See all past & upcoming NextGen events.
NextGen NYC
NextGen NYC Co-Chairs
Nancy Bello
Victor Zhao
Committee
Zachary Bader
Lindsay Barca
Arushi Bhatia
Julia Blackburn Otero
Madison Blanchard
Alix Brozman
Amanda Brozman
Nick Brozman
Jamie Brumberger Slocum
Griselda Cabrera
Clint Carlisle
Carolyn Chwalek
Becca Coleman
Matt Cowen
Abigail Debold
Malak Doss
Matt Dyer
Melissa Dzenis-Garcia
Robert Franciscovich
Cecilia Jorian
Katherine Kaze
Conner Krumholz
Renée Kuperman
Charlie Liu
Lara Luo
Sarah Margolis
Chris Martin
Amee Mehta
Andrew Minear
Isabelle Munteanu
Alice Nofzinger
Karra Puccia
Sari Rosenfeld
Tony Russo
Jennifer Schein
Katharine Scott
Milad Sedeh
Jeffrey Solomon
Viveca Tress
Georgia Tsignopoulos
Hunter Waters
NextGen Boston
Michelle Allison
Bank of America
Lucas Barrett
McDermott Will & Emery
Kate Bonavita
Morgan, Lewis & Bockius
David Braun
Gordon Brothers
Libby Canfield
Pathlight Capital
Bruna Carreiro
Lawson & Weitzen
Chris Carter
Morgan, Lewis & Bockius
Jessica Corr
Bank of America
Katherine Dobson Buckley
Morgan, Lewis & Bockius
Paige Edwards
Foley & Lardner
Brittany Fadous
Pathlight Capital
Emily Holt
Nixon Peabody
Peyton Jackson
Prescient Healthcare Group
Amy Kantor
Harvard T. H. Chan School of Public Health
Caroline Maxwell
Gordon Brothers, Committee Co-Chair
Morgan McCaskey
FTI Consulting
Elizabeth Myers
Nutter McClennen & Fish
Francesca Oliveira
Nutter McClennen & Fish
Ellie Penati
FGS Global
Haylee Rosenblatt
Boston Children’s Network Specialty Physicians
Ryan Rosenblatt
Sullivan & Worcester
Julia Schleppi
Carroll School
Arden Weilheimer
UMass Chan Medical School
Harrison West
FTI Consulting
Lily Wetherington
Pathlight Capital
#1
deadliest gynecologic
cancer
80%
of women are diagnosed
at an advanced stage
27%
of women have a 5-year
survival rate after an
advanced stage diagnosis